Craig Bijou
Stock Analyst at B of A Securities
(3.78)
# 757
Out of 5,044 analysts
63
Total ratings
60%
Success rate
54.64%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Maintains: Underperform | $18 → $9 | $8.81 | +2.16% | 2 | Jul 9, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $104 → $84 | $36.95 | +127.33% | 4 | Apr 25, 2025 | |
| TFX Teleflex | Downgrades: Underperform | $235 → $140 | $130.58 | +7.21% | 5 | Mar 4, 2025 | |
| BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $15.20 | +11.84% | 3 | Feb 20, 2025 | |
| GMED Globus Medical | Upgrades: Neutral | $80 → $97 | $62.75 | +54.58% | 4 | Jan 9, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $15.56 | +15.68% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $68.00 | +113.24% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $82.75 | +24.47% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $50.36 | +68.78% | 1 | Sep 11, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $79.40 | +8.31% | 2 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $71.75 | +32.40% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $15.79 | +127.99% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $8.52 | +428.17% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $120 | $4.81 | +2,394.80% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.86 | +517.28% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $16.59 | -21.62% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $16.02 | +162.17% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $545.39 | -57.83% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $375.93 | -38.82% | 4 | Jul 26, 2019 |
RxSight
Jul 9, 2025
Maintains: Underperform
Price Target: $18 → $9
Current: $8.81
Upside: +2.16%
PROCEPT BioRobotics
Apr 25, 2025
Maintains: Buy
Price Target: $104 → $84
Current: $36.95
Upside: +127.33%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $130.58
Upside: +7.21%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $15.20
Upside: +11.84%
Globus Medical
Jan 9, 2025
Upgrades: Neutral
Price Target: $80 → $97
Current: $62.75
Upside: +54.58%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $15.56
Upside: +15.68%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $68.00
Upside: +113.24%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $82.75
Upside: +24.47%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $50.36
Upside: +68.78%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $79.40
Upside: +8.31%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $71.75
Upside: +32.40%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $15.79
Upside: +127.99%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $8.52
Upside: +428.17%
Mar 25, 2020
Maintains: Overweight
Price Target: $15 → $120
Current: $4.81
Upside: +2,394.80%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $4.86
Upside: +517.28%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $16.59
Upside: -21.62%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $16.02
Upside: +162.17%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $545.39
Upside: -57.83%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $375.93
Upside: -38.82%